Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Franceschi

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patientsAlba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Anticancer Research|March 10, 2015
The effect of re-operation on survival in patients with recurrent glioblastomaEnrico Franceschi, Marco Bartolotti, Alicia Tosoni, et al.
Journal of Clinical Pathology|August 29, 2015
Contribution of microRNA analysis to characterisation of pancreatic lesions: a reviewMichela Visani, Giorgia Acquaviva, Sirio Fiorino, et al.
Expert Review of Anticancer Therapy|July 14, 2025
Emerging strategies and advances in the management of sinonasal carcinomaAlicia Tosoni, Maria Pia Foschini, Ernesto Pasquini, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trialMichele Reni, Stefano Cereda, Michele Milella, et al.
Oncotarget|September 15, 2017
Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II studyAlba A Brandes, Gaetano Finocchiaro, Vittorina Zagonel, et al.
Future Oncology (London, England)|May 22, 2020
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of ItalyAlba A Brandes, Andrea Ardizzoni, Fabrizio Artioli, et al.
Epilepsia|July 5, 2025
Tumor-related epilepsy in glioma: A multidisciplinary overviewRoberto Michelucci, Giada Pauletto, Antonio Silvani, et al.
Future Oncology (London, England)|May 10, 2018
Temozolomide rechallenge in recurrent glioblastoma: when is it useful?Enrico Franceschi, Giuseppe Lamberti, Michela Visani, et al.
Neuro-Oncology Advances|June 9, 2026
Educational needs in neuro-oncology: Insights from the European Society for Medical Oncology Central Nervous System Faculty SurveyOriol Mirallas, Giulia Cerretti, Anna Sophie Berghoff, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patientsAlba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Anticancer Research|March 10, 2015
The effect of re-operation on survival in patients with recurrent glioblastomaEnrico Franceschi, Marco Bartolotti, Alicia Tosoni, et al.
Journal of Clinical Pathology|August 29, 2015
Contribution of microRNA analysis to characterisation of pancreatic lesions: a reviewMichela Visani, Giorgia Acquaviva, Sirio Fiorino, et al.
Expert Review of Anticancer Therapy|July 14, 2025
Emerging strategies and advances in the management of sinonasal carcinomaAlicia Tosoni, Maria Pia Foschini, Ernesto Pasquini, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trialMichele Reni, Stefano Cereda, Michele Milella, et al.
Oncotarget|September 15, 2017
Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II studyAlba A Brandes, Gaetano Finocchiaro, Vittorina Zagonel, et al.
Future Oncology (London, England)|May 22, 2020
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of ItalyAlba A Brandes, Andrea Ardizzoni, Fabrizio Artioli, et al.
Epilepsia|July 5, 2025
Tumor-related epilepsy in glioma: A multidisciplinary overviewRoberto Michelucci, Giada Pauletto, Antonio Silvani, et al.
Future Oncology (London, England)|May 10, 2018
Temozolomide rechallenge in recurrent glioblastoma: when is it useful?Enrico Franceschi, Giuseppe Lamberti, Michela Visani, et al.
Neuro-Oncology Advances|June 9, 2026
Educational needs in neuro-oncology: Insights from the European Society for Medical Oncology Central Nervous System Faculty SurveyOriol Mirallas, Giulia Cerretti, Anna Sophie Berghoff, et al.
Pageof 17